文献速递慢性肾脏病遗传性与小管间质肾病

肾脏经导管动脉栓塞减少常染色体显性多囊肾病患者的肾囊肿感染

Kidney Transcatheter Arterial Embolization Reduces Kidney Cyst Infection in Patients With ADPKD.
PubMed 文献 · Kidney Int Rep · 2026-09-04

本回顾性队列纳入416例接受肾脏经导管动脉栓塞(TAE)的常染色体显性多囊肾病(ADPKD)患者,其中70例有既往肾囊肿感染史。TAE后肾囊肿感染年频率从0.291次降至0.087次(P<0.001),既往感染亚组从1.73±1.18降至0.49±0.96次/年(P<0.001),住院天数从34.1±26.1降至9.90±24.4天/年(P<0.001)。总肾脏体积缩小率(TKV-RR)>75%者无感染发生;TAE前感染频率、较低TKV-RR和TAE时使用抗生素是感染复发的独立危险因素。

要点

  • TAE可显著降低ADPKD患者肾囊肿感染年频率和住院天数。
  • TKV-RR>75%的患者TAE后未观察到感染。
  • TAE前感染频率高、TKV-RR低和TAE时使用抗生素是复发独立危险因素。

核心结论

  • 肾脏TAE是减少ADPKD患者肾囊肿感染的有前景的技术。
  • TAE应在感染完全缓解且无需抗生素治疗后进行,但即使持续使用抗生素者TAE仍减少囊肿感染。
  • 早期、广泛栓塞可能对高危患者尤其有益。

研究设计与样本

  • 回顾性队列研究,纳入416例接受肾脏TAE的ADPKD患者(主要队列),其中70例有既往肾囊肿感染。
  • 主要结局为肾囊肿感染年频率,次要结局包括住院时长,采用多变量线性回归识别TAE后感染复发的危险因素。

主要发现

  • 主要队列中,囊肿感染频率从TAE前0.291次/年降至TAE后0.087次/年(P<0.001)。
  • 既往感染亚组中,感染频率从1.73±1.18降至0.49±0.96次/年(P<0.001),住院天数从34.1±26.1降至9.90±24.4天/年(P<0.001)。
  • TKV-RR>75%的患者未观察到感染。
  • 多变量分析显示TAE前感染频率(β=0.23;P=0.017)、较低TKV-RR(β=-0.01;P=0.034)和TAE时使用抗生素(β=0.68;P=0.007)是TAE后感染复发的独立危险因素。
  • 即使持续使用抗生素的患者,TAE后感染频率仍下降。

临床怎么用

  • 对ADPKD反复肾囊肿感染患者可考虑肾脏TAE以降低感染频率和住院负担。
  • TAE宜在感染完全缓解且停用抗生素后进行,但对持续抗生素使用者仍可获益。
  • 追求更大的总肾脏体积缩小率(如>75%)可能进一步降低感染风险。

局限性

  • 回顾性设计可能存在选择偏倚和混杂。
  • 单中心或特定人群结果外推需谨慎。
  • 原文未报告样本量以外的多中心验证数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Kidney cyst infections are serious complications in autosomal dominant polycystic kidney disease (ADPKD). Kidney transcatheter arterial embolization (TAE) reduces kidney volume in this population. We tested the hypothesis that TAE could prevent kidney cyst infections. METHODS: This retrospective cohort study included 416 patients with ADPKD who underwent kidney TAE (primary cohort), including 70 patients with a previous kidney cyst infection. The primary outcome was the annual frequency of kidney cyst infections. Secondary outcomes included hospitalization duration. The risk factors for post-TAE infection recurrence were identified by multivariable linear regression. RESULTS: In the primary cohort, the frequency of cyst infections decreased from 0.291 episodes per year pre-TAE to 0.087 post-TAE (P < 0.001). In the subgroup with a previous infection, the frequency decreased from 1.73 ± 1.18 to 0.49 ± 0.96 episodes per year (P < 0.001), and hospitalization days decreased from 34.1 ± 26.1 to 9.90 ± 24.4 days per year (P < 0.001). The reduction effect was pronounced in patients with a greater total kidney volume reduction rate (TKV-RR). No infections were observed in patients who achieved a TKV-RR > 75%. Multivariable analysis revealed pre-TAE infection frequency (β = 0.23; P = 0.017), a lower TKV-RR (β = -0.01; P = 0.034), and antibiotic use at TAE (β = 0.68; P = 0.007) as independent risk factors for post-TAE infection recurrence. Even among patients who consistently used antibiotics, the infection frequency decreased post-TAE. CONCLUSION: Kidney TAE is a promising technique for reducing kidney cyst infections in patients with ADPKD. TAE should be performed after full remission without antibiotic therapy, but TAE reduces cyst infection even in consistent antibiotic users. Early, extensive embolization might be particularly beneficial in patients at high-risk.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Yoshimura Y, Suwabe T, Sekine A, et al. Kidney Transcatheter Arterial Embolization Reduces Kidney Cyst Infection in Patients With ADPKD. Kidney Int Rep. 2026. PMID: 42840242. doi:10.1016/j.ekir.2026.107068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。